vs
STANDARD BIOTOOLS INC.（LAB）与FiscalNote Holdings, Inc.（NOTE）财务数据对比。点击上方公司名可切换其他公司
FiscalNote Holdings, Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$22.2M vs $19.6M），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -24.7%），FiscalNote Holdings, Inc.自由现金流更多（$-1.9M vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -16.8%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FiscalNote Holdings, Inc.（常称FiscalNote）是一家上市的软件数据与传媒企业，总部位于美国华盛顿特区，2013年由三位创始人创立。核心业务为通过政府关系管理服务FiscalNote GRM提供软件工具、平台、数据服务与资讯，同时依托人工智能平台分析美国待审议法案相关内容。
LAB vs NOTE — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $22.2M |
| 净利润 | $-34.7M | — |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | -83.7% |
| 净利率 | -177.4% | — |
| 营收同比 | -11.5% | -24.7% |
| 净利润同比 | -28.8% | — |
| 每股收益（稀释后） | $-0.09 | $-2.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $22.2M | ||
| Q3 25 | $19.6M | $22.4M | ||
| Q2 25 | $21.8M | $23.3M | ||
| Q1 25 | $40.8M | $27.5M | ||
| Q4 24 | — | $29.5M | ||
| Q3 24 | $22.1M | $29.4M | ||
| Q2 24 | $22.5M | $29.2M | ||
| Q1 24 | $45.5M | $32.1M |
| Q4 25 | — | — | ||
| Q3 25 | $-34.7M | $-24.9M | ||
| Q2 25 | $-33.5M | $-13.3M | ||
| Q1 25 | $-26.0M | $-4.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.9M | $-14.9M | ||
| Q2 24 | $-45.7M | $-12.8M | ||
| Q1 24 | $-32.2M | $50.6M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | -83.7% | ||
| Q3 25 | -168.5% | -43.4% | ||
| Q2 25 | -118.1% | -31.9% | ||
| Q1 25 | -80.8% | -50.0% | ||
| Q4 24 | — | -19.4% | ||
| Q3 24 | -120.9% | -23.1% | ||
| Q2 24 | -134.5% | -27.2% | ||
| Q1 24 | -132.2% | -35.6% |
| Q4 25 | — | — | ||
| Q3 25 | -177.4% | -110.8% | ||
| Q2 25 | -153.7% | -57.0% | ||
| Q1 25 | -63.8% | -15.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -122.0% | -50.7% | ||
| Q2 24 | -203.3% | -43.6% | ||
| Q1 24 | -70.6% | 157.6% |
| Q4 25 | — | $-2.81 | ||
| Q3 25 | $-0.09 | $-1.73 | ||
| Q2 25 | $-0.09 | $-0.08 | ||
| Q1 25 | $-0.07 | $-0.03 | ||
| Q4 24 | — | $1.88 | ||
| Q3 24 | $-0.07 | $-1.33 | ||
| Q2 24 | $-0.12 | $-0.09 | ||
| Q1 24 | $-0.27 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $26.3M |
| 总债务越低越好 | — | $128.4M |
| 股东权益账面价值 | $399.7M | $62.0M |
| 总资产 | $539.6M | $255.1M |
| 负债/权益比越低杠杆越低 | — | 2.07× |
8季度趋势，按日历期对齐
| Q4 25 | — | $26.3M | ||
| Q3 25 | $129.4M | $31.2M | ||
| Q2 25 | $158.6M | $38.5M | ||
| Q1 25 | $150.9M | $46.3M | ||
| Q4 24 | — | $34.6M | ||
| Q3 24 | $210.6M | $32.7M | ||
| Q2 24 | $269.8M | $37.7M | ||
| Q1 24 | $287.1M | $43.6M |
| Q4 25 | — | $128.4M | ||
| Q3 25 | — | $131.5M | ||
| Q2 25 | — | $116.7M | ||
| Q1 25 | — | $118.0M | ||
| Q4 24 | — | $147.1M | ||
| Q3 24 | $55.2M | $152.2M | ||
| Q2 24 | $55.1M | $145.9M | ||
| Q1 24 | $55.0M | $153.0M |
| Q4 25 | — | $62.0M | ||
| Q3 25 | $399.7M | $75.5M | ||
| Q2 25 | $424.5M | $95.1M | ||
| Q1 25 | $454.6M | $98.7M | ||
| Q4 24 | — | $97.8M | ||
| Q3 24 | $489.3M | $98.5M | ||
| Q2 24 | $510.3M | $106.9M | ||
| Q1 24 | $577.3M | $106.1M |
| Q4 25 | — | $255.1M | ||
| Q3 25 | $539.6M | $273.9M | ||
| Q2 25 | $557.0M | $288.3M | ||
| Q1 25 | $579.6M | $299.7M | ||
| Q4 24 | — | $326.2M | ||
| Q3 24 | $681.5M | $337.9M | ||
| Q2 24 | $708.7M | $346.3M | ||
| Q1 24 | $777.7M | $357.8M |
| Q4 25 | — | 2.07× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | 1.23× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 1.50× | ||
| Q3 24 | 0.11× | 1.54× | ||
| Q2 24 | 0.11× | 1.36× | ||
| Q1 24 | 0.10× | 1.44× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-279.0K |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-1.9M |
| 自由现金流率自由现金流/营收 | -118.1% | -8.7% |
| 资本支出强度资本支出/营收 | 4.5% | 7.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-18.6M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-279.0K | ||
| Q3 25 | $-22.2M | $-8.3M | ||
| Q2 25 | $-20.7M | $-6.2M | ||
| Q1 25 | $-30.3M | $3.3M | ||
| Q4 24 | — | $-1.3M | ||
| Q3 24 | $-27.9M | $-3.0M | ||
| Q2 24 | $-39.0M | $-3.7M | ||
| Q1 24 | $-62.5M | $2.7M |
| Q4 25 | — | $-1.9M | ||
| Q3 25 | $-23.1M | $-10.4M | ||
| Q2 25 | $-22.6M | $-7.7M | ||
| Q1 25 | $-35.3M | $1.3M | ||
| Q4 24 | — | $-3.4M | ||
| Q3 24 | $-30.1M | $-5.4M | ||
| Q2 24 | $-41.0M | $-6.5M | ||
| Q1 24 | $-63.3M | $1.0M |
| Q4 25 | — | -8.7% | ||
| Q3 25 | -118.1% | -46.2% | ||
| Q2 25 | -103.6% | -33.0% | ||
| Q1 25 | -86.6% | 4.7% | ||
| Q4 24 | — | -11.4% | ||
| Q3 24 | -136.4% | -18.4% | ||
| Q2 24 | -182.2% | -22.1% | ||
| Q1 24 | -138.9% | 3.3% |
| Q4 25 | — | 7.4% | ||
| Q3 25 | 4.5% | 9.3% | ||
| Q2 25 | 8.7% | 6.4% | ||
| Q1 25 | 12.4% | 7.2% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | 10.2% | 8.3% | ||
| Q2 24 | 8.6% | 9.4% | ||
| Q1 24 | 1.7% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
NOTE
| Subscription | $21.2M | 95% |
| Advisory Advertising And Other | $1.0M | 5% |
